{"id":"https://openalex.org/A5154909197","orcid":"https://orcid.org/0009-0008-8799-5851","observed_orcids":["https://orcid.org/0009-0008-8799-5851"],"display_name":"Kerstin Pfeifer","raw_author_names":["Kerstin Pfeifer","Pfeifer, Kerstin"],"full_name":"Kerstin Pfeifer","works_count":4,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5154909197","orcid":"https://orcid.org/0009-0008-8799-5851","observed_orcids":["https://orcid.org/0009-0008-8799-5851"]},"affiliations":[{"institution":{"id":"https://openalex.org/I123859907","ror":"https://ror.org/05ex5vz81","display_name":"Federal Institute for Drugs and Medical Devices","country_code":"DE","type":"funder","lineage":["https://openalex.org/I123859907"]},"years":[2026,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I123859907","ror":"https://ror.org/05ex5vz81","display_name":"Federal Institute for Drugs and Medical Devices","country_code":"DE","type":"funder","lineage":["https://openalex.org/I123859907"]}],"topics":[{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","count":3,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":3,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10350","display_name":"Electronic Health Records Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":1,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","value":2.23e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":1.16e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","value":9.4e-06,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":7.6e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","value":4.7e-06,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","score":0.7031000256538391},{"id":"39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","score":0.39800000190734863},{"id":"133462117","wikidata":"https://www.wikidata.org/wiki/Q4929239","display_name":"Data collection","score":0.32510000467300415},{"id":"2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","score":0.31459999084472656},{"id":"69360830","wikidata":"https://www.wikidata.org/wiki/Q1172237","display_name":"Data Protection Act 1998","score":0.3082999885082245}],"counts_by_year":[{"year":2024,"works_count":3,"oa_works_count":3,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Kerstin Pfeifer","Pfeifer, Kerstin"],"block_key":"k pfeifer","works_api_url":"https://api.openalex.org/works?filter=author.id:A5154909197","updated_date":"2026-10-15T12:44:11","created_date":"2025-10-10T00:00:00"}